Radiation Applications

Nuclear Medicine / Pallas And NRG To Announce Detailed Development Proposal

By David Dalton
15 January 2021

Pallas And NRG To Announce Detailed Development Proposal
The HFR research reactor at Petten is 60 years old. Courtesy NRG.
NRG and Pallas of the Netherlands intend to announce a detailed proposal this spring for working together as a single organisation in the development and production of nuclear medicines, and construction of a new research reactor, Petten-based NRG said.

Want to know more?
Sign up.

Pen Use this content

Tags


Related